Clinical practice guideline: Sudden hearing loss

Otolaryngology - Head and Neck Surgery

Volumn 146, Issue SUPPL.3, 2012, Pages

  Stachler, Robert J ^a   Chandrasekhar, Sujana S ^b   Archer, Sanford M ^c   Rosenfeld, Richard M ^d   Schwartz, Seth R ^e   Barrs, David M ^f   Brown, Steven R ^g   Fife, Terry D ^g   Ford, Peg ^h   Ganiats, Theodore G ⁱ   Hollingsworth, Deena B ^j   Lewandowski, Christopher A ^a   Montano, Joseph J ^k   Saunders, James E ^l   Tucci, Debara L ^m   Valente, Michael ⁿ   Warren, Barbara E ^o   Yaremchuk, Kathleen L ^a   Robertson, Peter J ^p  

^a HENRY FORD HOSPITAL   (United States)

^b New York Otology   (United States)

^c UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^d LONG ISLAND COLLEGE HOSPITAL   (United States)

^e VIRGINIA MASON MEDICAL CENTER   (United States)

^f MAYO CLINIC   (United States)

^g UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^h University of California San Diego ^*

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j Henry Ford Hospital   (United States)

^k WEILL CORNELL MEDICAL COLLEGE   (United States)

^l DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^m DUKE UNIVERSITY MEDICAL CENTER   (United States)

ⁿ WASHINGTON UNIVERSITY   (United States)

^o CITY UNIVERSITY OF NEW YORK   (United States)

^p American Academy of Otolaryngology   (United States)

more..

Author keywords

Evidence based medicine; Hyperbaric oxygen; Intratympanic steroids; Practice guidelines; Sudden hearing loss; Sudden sensorineural hearing loss

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; METHYLPREDNISOLONE; PREDNISONE;

ADULT; ANAMNESIS; APPETITE; ARTICLE; AUDIOMETRY; AUDITORY RESPONSE; BLEEDING; BONE NECROSIS; CATARACT; CONDUCTION DEAFNESS; CUSHING SYNDROME; DIAGNOSTIC ACCURACY; DIZZINESS; DRUG EFFICACY; EARDRUM PERFORATION; EVIDENCE BASED MEDICINE; FOLLOW UP; GASTRITIS; HUMAN; HYPERBARIC OXYGEN; HYPERGLYCEMIA; HYPERTENSION; INFECTION; INSOMNIA; META ANALYSIS; MOOD CHANGE; MYOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPPORTUNISTIC INFECTION; OSTEOPOROSIS; PAIN; PANCREATITIS; PATIENT EDUCATION; PERCEPTION DEAFNESS; PHOTOSENSITIVITY; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; RISK BENEFIT ANALYSIS; SIDE EFFECT; SLEEP; SUDDEN DEAFNESS; SWEATING; SYNCOPE; THIRST; UNITED STATES; VERTIGO; WEIGHT GAIN;

EVIDENCE-BASED MEDICINE; GLUCOCORTICOIDS; HEARING LOSS, SUDDEN; HUMANS; HYPERBARIC OXYGENATION; INJECTIONS; OTOLARYNGOLOGY; TYMPANIC MEMBRANE;

EID: 84859011069     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599812436449     Document Type: Article

References (251)

1. Byl FM. Seventy-six cases of presumed sudden hearing loss occurring in 1973: prognosis and incidence. Laryngoscope. 1977;87(5, pt 1):817-825.
2. Mattox DE, Simmons FB. Natural history of sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol. 1977;86(4, pt 1):463-480. (Pubitemid 8161819)
3. National Institute of Deafness and Communication Disorders. Sudden deafness. 2000. http://www.nidcd.nih.gov/health/hearing/ sudden.htm. Accessed May 18, 2011.
4. Saunders JE, Luxford WM, Devgan KK, Fetterman BL. Sudden hearing loss in acoustic neuroma patients. Otolaryngol Head Neck Surg. 1995;113(1):23-31.
5. Rauch SD. Clinical practice: idiopathic sudden sensorineural hearing loss. N Engl J Med. 2008;359(8):833-840.
6. Conlin AE, Parnes LS. Treatment of sudden sensorineural hearing loss, II: a meta-analysis. Arch Otolaryngol Head Neck Surg. 2007;133(6):582-586. (Pubitemid 46974888)
7. Conlin AE, Parnes LS. Treatment of sudden sensorineural hearing loss, I: a systematic review. Arch Otolaryngol Head Neck Surg. 2007;133(6):573-581. (Pubitemid 46974887)
8. Fetterman BL, Saunders JE, Luxford WM. Prognosis and treatment of sudden sensorineural hearing loss. Am J Otol. 1996;17(4):529-536. (Pubitemid 26254906)
9. Haynes DS, O'Malley M, Cohen S, Watford K, Labadie RF. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. Laryngoscope. 2007;117(1):3-15. (Pubitemid 46066055)
10. Penido Nde O, Ramos HV, Barros FA, Cruz OL, Toledo RN. Clinical, etiological and progression factors of hearing in sudden deafness. Braz J Otorhinolaryngol. 2005;71(5):633-638.
11. Hol MK, Bosman AJ, Snik AF, Mylanus EA, Cremers CW. Bone-anchored hearing aids in unilateral inner ear deafness: an evaluation of audiometric and patient outcome measurements. Otol Neurotol. 2005;26(5):999-1006. (Pubitemid 41330718)
12. Nadol J, Wilson W. Treatment of sudden hearing loss is illogical. In: Snow J, ed. Controversy in Otolaryngology. Philadelphia: W. B. Saunders; 1980:22-32.
13. Rauch SD, Halpin CF, Antonelli PJ, et al. Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial. JAMA. 2011;305(20):2071-2079.
14. Byl FM Jr. Sudden hearing loss: eight years' experience and suggested prognostic table. Laryngoscope. 1984;94(5, pt 1):647-661. (Pubitemid 14105743)
15. Klemm E, Deutscher A, Mosges R. A present investigation of the epidemiology in idiopathic sudden sensorineural hearing loss [in German]. Laryngorhinootologie. 2009;88(8):524-527.
16. Wei BP, Mubiru S, O'Leary S. Steroids for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev. 2006;(1):CD003998.
17. Shaia FT, Sheehy JL. Sudden sensori-neural hearing impairment: a report of 1,220 cases. Laryngoscope. 1976;86(3):389-398.
18. Chiossoine-Kerdel JA, Baguley DM, Stoddart RL, Moffat DA. An investigation of the audiologic handicap associated with unilateral sudden sensorineural hearing loss. Am J Otol. 2000;21(5):645-651.
19. Wie OB, Pripp AH, Tvete O. Unilateral deafness in adults: effects on communication and social interaction. Ann Otol Rhinol Laryngol. 2010;119(11):772-781.
20. Borton SA, Mauze E, Lieu JE. Quality of life in children with unilateral hearing loss: a pilot study. Am J Audiol. 2010;19(1):61-72.
21. Carlsson PI, Hall M, Lind KJ, Danermark B. Quality of life, psychosocial consequences, and audiological rehabilitation after sudden sensorineural hearing loss. Int J Audiol. 2011;50(2): 139-144.
22. Mosges R, Koberlein J, Erdtracht B, Klingel R. Quality of life in patients with idiopathic sudden hearing loss: comparison of different therapies using the Medical Outcome Short Form (36) Health Survey questionnaire. Otol Neurotol. 2008;29(6):769-775.
23. Rosenfeld RM, Shiffman RN. Clinical practice guideline development manual: a quality-driven approach for translating evidence into action. Otolaryngol Head Neck Surg. 2009;140(6) (suppl 1):S1-S43.
24. Shiffman RN, Shekelle P, Overhage JM, Slutsky J, Grimshaw J, Deshpande AM. Standardized reporting of clinical practice guidelines: a proposal from the Conference on Guideline Standardization. Ann Intern Med. 2003;139(6):493-498. (Pubitemid 38124575)
25. Shiffman RN, Dixon J, Brandt C, et al. The GuideLine Implementability Appraisal (GLIA): development of an instrument to identify obstacles to guideline implementation. BMC Med Inform Decis Mak. 2005;5:23.
26. Classifying recommendations for clinical practice guidelines. Pediatrics. 2004;114(3):874-877.
27. OCEBM Levels of Evidence Working Group. The Oxford 2011 Levels of Evidence. Oxford Centre for Evidence-Based Medicine. http://www.cebm.net/index. aspx?o=5653
28. Eddy DM. A Manual for Assessing Health Practices and Designing Practice Policies: The Explicit Approach. Philadelphia, PA: American College of Physicians; 1992.
29. Choudhry NK, Stelfox HT, Detsky AS. Relationships between authors of clinical practice guidelines and the pharmaceutical industry. JAMA. 2002;287(5):612-617. (Pubitemid 34252013)
30. Detsky AS. Sources of bias for authors of clinical practice guidelines. CMAJ. 2006;175(9):1033, 1035.
31. Roland PS, Smith TL, Schwartz SR, et al. Clinical practice guideline: cerumen impaction. Otolaryngol Head Neck Surg. 2008;139(3)(suppl 2):S1-S21.
32. Stankiewicz JA, Mowry HJ. Clinical accuracy of tuning fork tests. Laryngoscope. 1979;89(12):1956-1963. (Pubitemid 10249733)
33. Burgess LP, Frankel SF, Lepore ML, Yim DW. Tuning fork screening for sudden hearing loss. Mil Med. 1988;153(9):456-458.
34. Bagai A, Thavendiranathan P, Detsky AS. Does this patient have hearing impairment? JAMA. 2006;295(4):416-428. (Pubitemid 43144978)
35. Miltenburg DM. The validity of tuning fork tests in diagnosing hearing loss. J Otolaryngol. 1994;23(4):254-259. (Pubitemid 24270569)
36. Browning GG, Swan IR, Chew KK. Clinical role of informal tests of hearing. J Laryngol Otol. 1989;103(1):7-11. (Pubitemid 19044431)
37. Chau JK, Lin JR, Atashband S, Irvine RA, Westerberg BD. Systematic review of the evidence for the etiology of adult sudden sensorineural hearing loss. Laryngoscope. 2010;120(5):1011-1021.
38. Haberkamp TJ, Tanyeri HM. Management of idiopathic sudden sensorineural hearing loss. Am J Otol. 1999;20(5):587-592; discussion 593-595.
39. Semaan MT, Megerian CA. Contemporary perspectives on the pathophysiology of Meniere's disease: implications for treatment. Curr Opin Otolaryngol Head Neck Surg. 2010;18(5):392-398.
40. St Clair EW, McCallum RM. Cogan's syndrome. Curr Opin Rheumatol. 1999;11(1):47-52. (Pubitemid 29057580)
41. McCabe BF. Autoimmune inner ear disease: results of therapy. Adv Otorhinolaryngol. 1991;46:78-81.
42. Kidwell CS, Warach S. Acute ischemic cerebrovascular syndrome: diagnostic criteria. Stroke. 2003;34(12):2995-2998. (Pubitemid 37517783)
43. Sattin JA, Olson SE, Liu L, Raman R, Lyden PD. An expedited code stroke protocol is feasible and safe. Stroke. 2006;37(12):2935-2939. (Pubitemid 44900812)
44. Furie KL, Kasner SE, Adams RJ, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42(1):227-276.
45. Amarenco P, Rosengart A, DeWitt LD, Pessin MS, Caplan LR. Anterior inferior cerebellar artery territory infarcts: mechanisms and clinical features. Arch Neurol. 1993;50(2):154-161. (Pubitemid 23054798)
46. Oas JG, Baloh RW. Vertigo and the anterior inferior cerebellar artery syndrome. Neurology. 1992;42(12):2274-2279. (Pubitemid 23001586)
47. Lee H, Kim JS, Chung EJ, et al. Infarction in the territory of anterior inferior cerebellar artery: spectrum of audiovestibular loss. Stroke. 2009;40(12):3745-3751.
48. Lee H, Cho Y-W. Auditory disturbance as a prodrome of anterior inferior cerebellar artery infarction. J Neurol Neurosurg Psychiatry. 2003;74(12):1644-1648. (Pubitemid 37542053)
49. Fife TD, Baloh RW, Duckwiler GR. Isolated dizziness in vertebrobasilar insufficiency: clinical features, angiography, and follow-up. J Stroke Cerebrovasc Dis. 1994;4(1):4-12.
50. Lee H, Whitman GT, Lim JG, Lee SD, Park YC. Bilateral sudden deafness as a prodrome of anterior inferior cerebellar artery infarction. Arch Neurol. 2001;58(8):1287-1289. (Pubitemid 32751749)
51. Toyoda K, Hirano T, Kumai Y, Fujii K, Kiritoshi S, Ibayashi S. Bilateral deafness as a prodromal symptom of basilar artery occlusion. J Neurol Sci. 2002;193(2):147-150. (Pubitemid 34098946)
52. Starkstein SE, Federoff JP, Price TR, Leiguarda RC, Robinson RG. Neuropsychological and neuroradiologic correlates of emotional prosody comprehension. Neurology. 1994;44(3, pt 1):515-522. (Pubitemid 24098153)
53. Bahls FH, Chatrian GE, Mesher RA, Sumi SM, Ruff RL. A case of persistent cortical deafness: clinical, neurophysiologic, and neuropathologic observations. Neurology. 1988;38(9):1490-1493.
54. Leicester J. Central deafness and subcortical motor aphasia. Brain Lang. 1980;10(2):224-242. (Pubitemid 10010403)
55. Tanaka Y, Kamo T, Yoshida M, Yamadori A. 'So-called' cortical deafness: clinical, neurophysiological and radiological observations. Brain. 1991;114(pt 6):2385-2401.
56. Hausler R, Levine RA. Auditory dysfunction in stroke. Acta Otolaryngol. 2000;120(6):689-703. (Pubitemid 32511267)
57. Lee H, Baloh RW. Sudden deafness in vertebrobasilar ischemia: clinical features, vascular topographical patterns and long-term outcome. J Neurol Sci. 2005;228(1):99-104. (Pubitemid 39656501)
58. Lin HC, Chao PZ, Lee HC. Sudden sensorineural hearing loss increases the risk of stroke: a 5-year follow-up study. Stroke. 2008;39(10):2744-2748.
59. Lee H, Whitman GT, Lim JG, et al. Hearing symptoms in migrainous infarction. Arch Neurol. 2003;60(1):113-116. (Pubitemid 36078117)
60. Aarnisalo AA, Suoranta H, Ylikoski J. Magnetic resonance imaging findings in the auditory pathway of patients with sudden deafness. Otol Neurotol. 2004;25(3):245-249. (Pubitemid 39079803)
61. St Martin MB, Hirsch BE. Imaging of hearing loss. Otolaryngol Clin North Am. 2008;41(1):157-178, vi-vii. (Pubitemid 351186580)
62. American College of Radiology (ACR). Appropriateness criteria- rating round information. http://www.acr.org/secondarymainme nucategories/quality- safety/app-criteria.aspx
63. American College of Radiology (ACR). Expert Panel on Neurologic Imaging: Turski PA, Wippold FJ II, Cornelius RS, et al. ACR appropriateness criteria, vertigo and hearing loss. 1996 (last review date: 2008). http://www.acr.org/ SecondaryMain- MenuCategories/quality-safety/app-criteria/pdf/ExpertPanelon- NeurologicImaging/VertigoandHearingLossDoc14.aspx
64. American College of Radiology (ACR). Appropriateness criteria radiation dose assessment introduction. http://www.acr.org/ SecondaryMainMenuCategories/ quality-safety/app-criteria/ RRLInformation.aspx
65. Lipkin AF, Jenkins HA. Role of air contrast computed tomography in diagnosis of small acoustic neuromas. Laryngoscope. 1984;94(7):890-895. (Pubitemid 14085103)
66. Meijenhorst GC, van der Lande BA, Baretta-Kooi HH, van der Kooi CR, Kroes AF, van Gasteren JH. High-resolution CT and air CT cisternography in the diagnosis of acoustic neuromas. Diagn Imaging Clin Med. 1984;53(3):120-127. (Pubitemid 14111676)
67. Khangure MS, Dolan KD. High resolution CT air cisternography in the diagnosis of small acoustic neuromas. Head Neck Surg. 1983;5(6):489-494. (Pubitemid 13035280)
68. Samii M, Matthies C, Tatagiba M. Intracanalicular acoustic neurinomas. Neurosurgery. 1991;29(2):189-198; discussion 198-199.
69. Kamei T, Nakashima A, Seto H, Kakishita M. Comparison between air CT and MRI in the detection of small acoustic neurinomas. Radiat Med. 1989;7(1):16-22. (Pubitemid 19142567)
70. Wilms G, Decrop E, Plets C, et al. Magnetic resonance imaging in acoustic neurinoma: comparison with CT. J Belge Radiol. 1989;72(3):151-158. (Pubitemid 19188508)
71. Hashimoto S, Kawase T, Furukawa K, Takasaka T. Strategy for the diagnosis of small acoustic neuromas. Acta Otolaryngol Suppl. 1991;481:567-569.
72. House JW, Waluch V, Jackler RK. Magnetic resonance imaging in acoustic neuroma diagnosis. Ann Otol Rhinol Laryngol. 1986;95(1, pt 1):16-20. (Pubitemid 16132604)
73. Mikhael MA, Wolff AP, Ciric IS. Current concepts in neuroradiological diagnosis of acoustic neuromas. Laryngoscope. 1987;97(4):471-476. (Pubitemid 17059823)
74. Curati WL, Graif M, Kingsley DP, King T, Scholtz CL, Steiner RE. MRI in acoustic neuroma: a review of 35 patients. Neuroradiology. 1986;28(3):208-214. (Pubitemid 16075027)
75. Davidson HC. Imaging evaluation of sensorineural hearing loss. Semin Ultrasound CT MR. 2001;22(3):229-249. (Pubitemid 32588470)
76. Wilson WR, Byl FM, Laird N. The efficacy of steroids in the treatment of idiopathic sudden hearing loss: a double-blind clinical study. Arch Otolaryngol. 1980;106(12):772-776. (Pubitemid 11194190)
77. Burton MJ, Harvey RJ. Idiopathic sudden sensorineural hearing loss. In: Scott-Brown WG, Gleeson M, eds. Scott-Browns Otorhinolaryngology, Head and Neck Surgery. 7th ed. Oxford, UK: Oxford University Press; 2008.
78. American Speech-Language-Hearing Association. Preferred practice patterns for the profession of audiology. 2006. www. asha.org/policy
79. American National Standards Institute (ANSI). Maximum Permissible Ambient Noise Levels for Audiometric Test Rooms (ANSI S3.1-R2003). New York: ANSI; 2003.
80. American National Standards Institute (ANSI). Specifications for Audiometers (ANSI S3.6-R2004). New York: ANSI; 2004.
81. American Speech-Language-Hearing Association. Guidelines for manual pure-tone threshold audiometry. 2005. www.asha .org/policy
82. American National Standards Institute (ANSI). Methods for Manual Pure-Tone Threshold Audiometry (ANSI S3.21-1978, R-1986). New York: ANSI; 1978.
83. American Speech-Language-Hearing Association. Guidelines for audiometric symbols. 1990. www.asha.org/policy
84. Halpin C, Rauch SD. Using audiometric thresholds and word recognition in a treatment study. Otol Neurotol. 2006;27(1):110-116. (Pubitemid 43011101)
85. Thornton AR, Raffin MJ. Speech-discrimination scores modeled as a binomial variable. J Speech Hear Res. 1978;21(3):507-518. (Pubitemid 9028176)
86. Garcia Berrocal JRG, Ramirez-Camacho R, Portero F, Vargas JA. Role of viral and Mycoplasma pneumoniae infection in idiopathic sudden sensorineural hearing loss. Acta Otolaryngol. 2000;120(7):835-839. (Pubitemid 32511254)
87. Garcia Berrocal JR, Ramirez-Camacho R, Vargas JA, Millan I. Does the serological testing really play a role in the diagnosis immune-mediated inner ear disease? Acta Otolaryngol. 2002;122(3):243-248. (Pubitemid 34538921)
88. Toubi E, Ben-David J, Kessel A, Halas K, Sabo E, Luntz M. Immune-mediated disorders associated with idiopathic sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol. 2004;113(6):445-449. (Pubitemid 38781302)
89. Cadoni G, Scipione S, Rocca B, et al. Lack of association between inherited thrombophilic risk factors and idiopathic sudden sensorineural hearing loss in Italian patients. Ann Otol Rhinol Laryngol. 2006;115(3):195-200.
90. Finizia C, Jonsson R, Hanner P. Serum and cerebrospinal fluid pathology in patients with sudden sensorineural hearing loss. Acta Otolaryngol. 2001;121(7):823-830. (Pubitemid 33065414)
91. Narozny W, Kuczkowski J, Mikaszewski B. Steroids promote recovery in sudden hearing loss. Otolaryngol Head Neck Surg. 2006;134(6):1068. (Pubitemid 43766543)
92. Cadoni G, Agostino S, Scipione S, Galli J. Low serum folate levels: a risk factor for sudden sensorineural hearing loss? Acta Otolaryngol. 2004;124(5):608-611. (Pubitemid 38858230)
93. Cadoni G, Scorpecci A, Cianfrone F, Giannantonio S, Paludetti G, Lippa S. Serum fatty acids and cardiovascular risk factors in sudden sensorineural hearing loss: a case-control study. Ann Otol Rhinol Laryngol. 2010;119(2):82-88.
94. Nordang L, Laurent C, Mollnes TE. Complement activation in sudden deafness. Arch Otolaryngol Head Neck Surg. 1998;124(6):633-636. (Pubitemid 28272927)
95. Sauvaget E, Kici S, Kania R, Herman P, Tran Ba Huy P. Sudden sensorineural hearing loss as a revealing symptom of vestibular schwannoma. Acta Otolaryngol. 2005;125(6):592-595. (Pubitemid 40874173)
96. Ramos HV, Barros FA, Yamashita H, Penido Nde O, Souza AC, Yamaoka WY. Magnetic resonance imaging in sudden deafness. Braz J Otorhinolaryngol. 2005;71(4):422-426. (Pubitemid 43161337)
97. Suzuki M, Hashimoto S, Kano S, Okitsu T. Prevalence of acoustic neuroma associated with each configuration of pure tone audiogram in patients with asymmetric sensorineural hearing loss. Ann Otol Rhinol Laryngol. 2010;119(9):615-618.
98. Nosrati-Zarenoe R, Hansson M, Hultcrantz E. Assessment of diagnostic approaches to idiopathic sudden sensorineural hearing loss and their influence on treatment and outcome. Acta Otolaryngol. 2010;130(3):384-391.
99. Fortnum H, O'Neill C, Taylor R, et al. The role of magnetic resonance imaging in the identification of suspected acoustic neuroma: a systematic review of clinical and cost effectiveness and natural history. Health Technol Assess. 2009;13(18):iii-iv, ix-xi, 1-154.
100. Pritchard C, Clapham L, Davis A, Lang DA, Neil-Dwyer G. Psycho-socio-economic outcomes in acoustic neuroma patients and their carers related to tumour size. Clin Otolaryngol Allied Sci. 2004;29(4):324-330. (Pubitemid 38981320)
101. Jacob A, Robinson LL Jr, Bortman JS, Yu L, Dodson EE, Welling DB. Nerve of origin, tumor size, hearing preservation, and facial nerve outcomes in 359 vestibular schwannoma resections at a tertiary care academic center. Laryngoscope. 2007;117(12):2087-2092. (Pubitemid 351339578)
102. Sughrue ME, Yang I, Aranda D, Kane AJ, Parsa AT. Hearing preservation rates after microsurgical resection of vestibular schwannoma. J Clin Neurosci. 2010;17(9):1126-1129.
103. Hasegawa T, Kida Y, Kobayashi T, Yoshimoto M, Mori Y, Yoshida J. Long-term outcomes in patients with vestibular schwannomas treated using gamma knife surgery: 10-year follow up. J Neurosurg. 2005;102(1):10-16. (Pubitemid 43186690)
104. Kano H, Kondziolka D, Khan A, Flickinger JC, Lunsford LD. Predictors of hearing preservation after stereotactic radiosurgery for acoustic neuroma. J Neurosurg. 2009;111(4):863-873.
105. Yang I, Sughrue ME, Han SJ, et al. Facial nerve preservation after vestibular schwannoma Gamma Knife radiosurgery. J Neurooncol. 2009;93(1):41-48.
106. Whitehouse K, Foroughi M, Shone G, Hatfield R. Vestibular schwannomas-when should conservative management be reconsidered? Br J Neurosurg. 2010;24(2):185-190.
107. Smouha EE, Yoo M, Mohr K, Davis RP. Conservative management of acoustic neuroma: a meta-analysis and proposed treatment algorithm. Laryngoscope. 2005;115(3):450-454. (Pubitemid 40327991)
108. Nikolopoulos TP, O'Donoghue GM. Acoustic neuroma management: an evidence-based medicine approach. Otol Neurotol. 2002;23(4):534-541. (Pubitemid 34774046)
109. Moffat DA, Hardy DG. Early diagnosis and surgical management of acoustic neuroma: is it cost effective? J R Soc Med. 1989;82(6):329-332. (Pubitemid 19267082)
110. Daniels RL, Shelton C, Harnsberger HR. Ultra high resolution nonenhanced fast spin echo magnetic resonance imaging: costeffective screening for acoustic neuroma in patients with sudden sensorineural hearing loss. Otolaryngol Head Neck Surg. 1998;119(4):364-369. (Pubitemid 28467383)
111. Fitzgerald DC, Mark AS. Sudden hearing loss: frequency of abnormal findings on contrast-enhanced MR studies. AJNR Am J Neuroradiol. 1998;19(8):1433-1436. (Pubitemid 30431032)
112. Schick B, Brors D, Koch O, Schafers M, Kahle G. Magnetic resonance imaging in patients with sudden hearing loss, tinnitus and vertigo. Otol Neurotol. 2001;22(6):808-812. (Pubitemid 33101327)
113. Cadoni G, Cianfoni A, Agostino S, et al. Magnetic resonance imaging findings in sudden sensorineural hearing loss. J Otolaryngol. 2006;35(5):310-316. (Pubitemid 44785677)
114. Papanikolaou V, Khan MH, Keogh IJ. Incidental findings on MRI scans of patients presenting with audiovestibular symptoms. BMC Ear Nose Throat Disord. 2010;10:6.
115. Prince MR, Zhang H, Zou Z, Staron RB, Brill PW. Incidence of immediate gadolinium contrast media reactions. AJR Am J Roentgenol. 2011;196(2):W138-W143.
116. Bhave G, Lewis JB, Chang SS. Association of gadolinium based magnetic resonance imaging contrast agents and nephrogenic systemic fibrosis. J Urol. 2008;180(3):830-835; discussion 835.
117. Montaguti M, Bergonzoni C, Zanetti MA, Rinaldi Ceroni A. Comparative evaluation of ABR abnormalities in patients with and without neurinoma of VIII cranial nerve. Acta Otorhinolaryngol Ital. 2007;27(2):68-72.
118. Chandrasekhar SS, Brackmann DE, Devgan KK. Utility of auditory brainstem response audiometry in diagnosis of acoustic neuromas. Am J Otol. 1995;16(1):63-67.
119. El-Kashlan HK, Eisenmann D, Kileny PR. Auditory brain stem response in small acoustic neuromas. Ear Hear. 2000; 21(3):257-262. (Pubitemid 30447890)
120. Schmidt RJ, Sataloff RT, Newman J, Spiegel JR, Myers DL. The sensitivity of auditory brainstem response testing for the diagnosis of acoustic neuromas. Arch Otolaryngol Head Neck Surg. 2001;127(1):19-22. (Pubitemid 32063981)
121. Musiek FE, Kibbe-Michal K, Geurkink NA, Josey AF, Glasscock M III. ABR results in patients with posterior fossa tumors and normal pure-tone hearing. Otolaryngol Head Neck Surg. 1986;94(5):568-573. (Pubitemid 16095956)
122. National Institute for Occupational Safety and Health. Hearing loss prevention. http://www.cdc.gov/niosh/programs/hlp/risks. html. Accessed July 25, 2011.
123. Kon AA. The shared decision-making continuum. JAMA. 2010;304(8):903-904.
124. Elwyn G, Edwards A. Shared Decision-Making in Health Care: Achieving Evidence-Based Patient Choice. 2nd ed. Oxford, UK: Oxford University Press; 2009.
125. Edwards A, Elwyn G. Involving patients in decision making and communicating risk: a longitudinal evaluation of doctors' attitudes and confidence during a randomized trial. J Eval Clin Pract. 2004;10(3):431-437. (Pubitemid 39093750)
126. O'Connor AM, Bennett CL, Stacey D, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2009;(3):CD001431.
127. Norris CH. Drugs affecting the inner ear: a review of their clinical efficacy, mechanisms of action, toxicity, and place in therapy. Drugs. 1988;36(6):754-772. (Pubitemid 19002887)
128. McCall AA, Swan EE, Borenstein JT, Sewell WF, Kujawa SG, McKenna MJ. Drug delivery for treatment of inner ear disease: current state of knowledge. Ear Hear. 2010;31(2):156-165.
129. Labus J, Breil J, Stutzer H, Michel O. Meta-analysis for the effect of medical therapy vs. placebo on recovery of idiopathic sudden hearing loss. Laryngoscope. 2010;120(9):1863-1871.
130. Moskowitz D, Lee KJ, Smith HW. Steroid use in idiopathic sudden sensorineural hearing loss. Laryngoscope. 1984;94(5, pt 1):664-666. (Pubitemid 14105745)
131. Stokroos RJ, Albers FW. Therapy of idiopathic sudden sensorineural hearing loss: a review of the literature. Acta Otorhinolaryngol Belg. 1996;50(1):77-84.
132. Chen CY, Halpin C, Rauch SD. Oral steroid treatment of sudden sensorineural hearing loss: a ten year retrospective analysis. Otol Neurotol. 2003;24(5):728-733. (Pubitemid 37122536)
133. Ghosh A, Jackson R. Best evidence topic report: steroids in sudden sensorineural hearing loss. Emerg Med J. 2005;22(10):732-733. (Pubitemid 41479635)
134. Slattery WH, Fisher LM, Iqbal Z, Friedman RA, Liu N. Intratympanic steroid injection for treatment of idiopathic sudden hearing loss. Otolaryngol Head Neck Surg. 2005;133(2):251-259. (Pubitemid 41125677)
135. Jeyakumar A, Francis D, Doerr T. Treatment of idiopathic sudden sensorineural hearing loss. Acta Otolaryngol. 2006;126(7):708-713. (Pubitemid 43995447)
136. Megighian D, Bolzan M, Barion U, Nicolai P. Epidemiological considerations in sudden hearing loss: a study of 183 cases. Arch Otorhinolaryngol. 1986;243(4):250-253. (Pubitemid 16008868)
137. Parnes LS, Sun AH, Freeman DJ. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope. 1999;109(7, pt 2):1-17. (Pubitemid 29315126)
138. Banerjee A, Parnes LS. Intratympanic corticosteroids for sudden idiopathic sensorineural hearing loss. Otol Neurotol. 2005;26(5):878-881. (Pubitemid 41330701)
139. Fitzgerald DC, McGuire JF. Intratympanic steroids for idiopathic sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol. 2007;116(4):253-256. (Pubitemid 46651179)
140. Cvorovic L, Deric D, Probst R, Hegemann S. Prognostic model for predicting hearing recovery in idiopathic sudden sensorineural hearing loss. Otol Neurotol. 2008;29(4):464-469.
141. Powell-Tuck J, Bown RL, Lennard-Jones JE. A comparison of oral prednisolone given as single or multiple daily doses for active proctocolitis. Scand J Gastroenterol. 1978;13(7):833-837. (Pubitemid 9067125)
142. UpToDate, Inc. Methylprednisolone: drug information. http:// www.uptodate.com/contents/methylprednisolone-drug-information. Accessed May 15, 2011.
143. Saag KG, Furst DE. Major side effects of systemic glucocorticords. http://www.uptodate.com/contents/major-side-effectsof- systemic-glucocorticoids? source=search-result&selected Title=1~150. Accessed May 18, 2011.
144. Drugs.com. MethylPREDNISolone Dose Pack. http:// www.drugs.com/mtm/ methylprednisolone-dose-pack.html. Accessed May 18, 2011.
145. Swartz SL, Dluhy RG. Corticosteroids: clinical pharmacology and therapeutic use. Drugs. 1978;16(3):238-255. (Pubitemid 9001468)
146. Holland EG, Taylor AT. Glucocorticoids in clinical practice. J Fam Pract. 1991;32(5):512-519.
147. Nash JJ, Nash AG, Leach ME, Poetker DM. Medical malpractice and corticosteroid use. Otolaryngol Head Neck Surg. 2011;144(1):10-15.
148. Alexander TH, Weisman MH, Derebery JM, et al. Safety of high-dose corticosteroids for the treatment of autoimmune inner ear disease. Otol Neurotol. 2009;30(4):443-448.
149. McDonough AK, Curtis JR, Saag KG. The epidemiology of glucocorticoid-associated adverse events. Curr Opin Rheumatol. 2008;20(2):131-137. (Pubitemid 351339883)
150. Chandrasekhar SS. Intratympanic dexamethasone for sudden sensorineural hearing loss: clinical and laboratory evaluation. Otol Neurotol. 2001;22(1):18-23. (Pubitemid 32182848)
151. Battista RA. Intratympanic dexamethasone for profound idiopathic sudden sensorineural hearing loss. Otolaryngol Head Neck Surg. 2005;132(6):902-905. (Pubitemid 40798414)
152. Battaglia A, Burchette R, Cueva R. Combination therapy (intratympanic dexamethasone + high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss. Otol Neurotol. 2008;29(4):453-460.
153. Ahn JH, Yoo MH, Yoon TH, Chung JW. Can intratympanic dexamethasone added to systemic steroids improve hearing outcome in patients with sudden deafness? Laryngoscope. 2008;118(2):279-282. (Pubitemid 351640202)
154. Filipo R, Covelli E, Balsamo G, Attanasio G. Intratympanic prednisolone therapy for sudden sensorineural hearing loss: a new protocol. Acta Otolaryngol. 2010;130(11):1209-1213.
155. Seggas I, Koltsidopoulos P, Bibas A, Tzonou A, Sismanis A. Intratympanic steroid therapy for sudden hearing loss: a review of the literature. Otol Neurotol. 2011;32(1):29-35.
156. Kakehata S, Sasaki A, Oji K, et al. Comparison of intratympanic and intravenous dexamethasone treatment on sudden sensorineural hearing loss with diabetes. Otol Neurotol. 2006;27(5):604-608. (Pubitemid 44180470)
157. Han CS, Park JR, Boo SH, et al. Clinical efficacy of initial intratympanic steroid treatment on sudden sensorineural hearing loss with diabetes. Otolaryngol Head Neck Surg. 2009;141(5):572-578.
158. Chandrasekhar SS, Rubinstein RY, Kwartler JA, et al. Dexamethasone pharmacokinetics in the inner ear: comparison of route of administration and use of facilitating agents. Otolaryngol Head Neck Surg. 2000;122(4):521-528. (Pubitemid 30210667)
159. Borden RC, Saunders JE, Berryhill WE, Krempl GA, Thompson DM, Queimado L. Hyaluronic acid hydrogel sustains the delivery of dexamethasone across the round window membrane. Audiol Neurootol. 2011;16(1):1-11.
160. Hamid M, Trune D. Issues, indications, and controversies regarding intratympanic steroid perfusion. Curr Opin Otolaryngol Head Neck Surg. 2008;16(5):434-440.
161. Hu A, Parnes LS. Intratympanic steroids for inner ear disorders: a review. Audiol Neurootol. 2009;14(6):373-382.
162. Doyle KJ, Bauch C, Battista R, et al. Intratympanic steroid treatment: a review. Otol Neurotol. 2004;25(6):1034-1039. (Pubitemid 39491693)
163. Alles MJ, der Gaag MA, Stokroos RJ. Intratympanic steroid therapy for inner ear diseases, a review of the literature. Eur Arch Otorhinolaryngol. 2006;263(9):791-797. (Pubitemid 44127302)
164. Hoffer ME, Balough BJ, Gottshall KR. Delivery of drugs to the inner ear. Curr Opin Otolaryngol Head Neck Surg. 2006;14(5):329-331. (Pubitemid 44410398)
165. Gill AL, Bell CN. Hyperbaric oxygen: its uses, mechanisms of action and outcomes. QJM. 2004;97(7):385-395. (Pubitemid 38967412)
166. Bennett MH, Kertesz T, Yeung P. Hyperbaric oxygen for idiopathic sudden sensorineural hearing loss and tinnitus. Cochrane Database Syst Rev. 2007;(1):CD004739.
167. Cavallazzi G, Pignataro L, Capaccio P. Italian experience in hyperbaric oxygen therapy for idiopathic sudden sensorineural hearing loss. Paper presented at: International Joint Meeting on Hyperbaric and Underwater Medicine; September 5-8, 1996; Milan, Italy.
168. Fattori B, Berrettini S, Casani A, Nacci A, De Vito A, De Iaco G. Sudden hypoacusis treated with hyperbaric oxygen therapy: a controlled study. Ear Nose Throat J. 2001;80(9):655-660. (Pubitemid 32896270)
169. Hoffman G, Bohmar D, Desloovere C. Hyperbaric oxygenation as a treatment
170. Hoffmann G, Bohmer D, Desloovere C. Hyperbaric oxygenation as a treatment for sudden deafness and acute tinnitus. In: Proceedings of the Eleventh International Congress on Hyperbaric Medicine. Flagstaff, AZ: Best Publishing; 1995.
171. Pilgramm M, Lamm H, Schumann K. Hyperbaric oxygen therapy in sudden deafness [in German]. Laryngol Rhinol Otol (Stuttg). 1985;64(7):351-354. (Pubitemid 15070423)
172. Schwab B, Flunkert C, Heermann R, Lenarz T. HBO in the therapy of cochlear dysfunctions: first results of a randomized study. In: EUBS Diving and Hyperbaric Medicine, Collected Manuscripts of XXIV Annual Scientific Meeting of the European Underwater and Baromedical Society. Stockholm: EUBS; 1998.
173. Topuz E, Yigit O, Cinar U, Seven H. Should hyperbaric oxygen be added to treatment in idiopathic sudden sensorineural hearing loss? Eur Arch Otorhinolaryngol. 2004;261(7):393-396. (Pubitemid 39141445)
174. Cekin E, Cincik H, Ulubil SA, Gungor A. Effectiveness of hyperbaric oxygen therapy in management of sudden hearing loss. J Laryngol Otol. 2009;123(6):609-612.
175. Plafki C, Peters P, Almeling M, Welslau W, Busch R. Complications and side effects of hyperbaric oxygen therapy. Aviat Space Environ Med. 2000;71(2):119-124. (Pubitemid 30070823)
176. Fernau JL, Hirsch BE, Derkay C, Ramasastry S, Schaefer SE. Hyperbaric oxygen therapy: effect on middle ear and eustachian tube function. Laryngoscope. 1992;102(1):48-52.
177. Korpinar S, Alkan Z, Yigit O, et al. Factors influencing the outcome of idiopathic sudden sensorineural hearing loss treated with hyperbaric oxygen therapy. Eur Arch Otorhinolaryngol. 2011;268(1):41-47.
178. Merchant SN, Durand ML, Adams JC. Sudden deafness: is it viral? ORL J Otorhinolaryngol Relat Spec. 2008;70(1):52-60; discussion 60-62. (Pubitemid 351196115)
179. Tucci DL, Farmer JC Jr, Kitch RD, Witsell DL. Treatment of sudden sensorineural hearing loss with systemic steroids and valacyclovir. Otol Neurotol. 2002;23(3):301-308. (Pubitemid 34506637)
180. Uri N, Doweck I, Cohen-Kerem R, Greenberg E. Acyclovir in the treatment of idiopathic sudden sensorineural hearing loss. Otolaryngol Head Neck Surg. 2003;128(4):544-549. (Pubitemid 36438431)
181. Westerlaken BO, Stokroos RJ, Dhooge IJ, Wit HP, Albers FW. Treatment of idiopathic sudden sensorineural hearing loss with antiviral therapy: a prospective, randomized, double-blind clinical trial. Ann Otol Rhinol Laryngol. 2003;112(11):993-1000. (Pubitemid 37429645)
182. Stokroos RJ, Albers FW, Tenvergert EM. Antiviral treatment of idiopathic sudden sensorineural hearing loss: a prospective, randomized, double-blind clinical trial. Acta Otolaryngol. 1998;118(4):488-495. (Pubitemid 28351326)
183. Fisch U, Nagahara K, Pollak A. Sudden hearing loss: circulatory. Am J Otol. 1984;5(6):488-491. (Pubitemid 15220390)
184. Schuknecht HF, Kimura RS, Naufal PM. The pathology of sudden deafness. Acta Otolaryngol. 1973;76(2):75-97.
185. Perlman HB, Kimura R, Fernandez C. Experiments on temporary obstruction of the internal auditory artery. Laryngoscope. 1959;69(6):591-613.
186. Mattox DE, Lyles CA. Idiopathic sudden sensorineural hearing loss. Am J Otol. 1989;10(3):242-247. (Pubitemid 19200447)
187. Reisser CH, Weidauer H. Ginkgo biloba extract EGb 761 or pentoxifylline for the treatment of sudden deafness: a randomized, reference-controlled, double-blind study. Acta Otolaryngol. 2001;121(5):579-584. (Pubitemid 32831798)
188. Mann W, Beck C. Calcium antagonists in the treatment of sudden deafness. Arch Otorhinolaryngol. 1986;243(3): 170-173. (Pubitemid 16074006)
189. Agarwal L, Pothier DD. Vasodilators and vasoactive substances for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev. 2009;(4):CD003422.
190. Suzuki H, Furukawa M, Kumagai M, et al. Defibrinogenation therapy for idiopathic sudden sensorineural hearing loss in comparison with high-dose steroid therapy. Acta Otolaryngol. 2003;123(1):46-50. (Pubitemid 36216510)
191. Huang TS, Chan ST, Ho TL, Su JL, Lee FP. Hypaque and steroids in the treatment of sudden sensorineural hearing loss. Clin Otolaryngol Allied Sci. 1989;14(1):45-51.
192. Fischer HW. Choices for intravascular contrast agents. Curr Probl Diagn Radiol. 1976;6(3):1-45.
193. Silverstein H, Jackson LE, Rosenberg SI. Silverstein Microwick™ for treatment of inner ear disease. Oper Techn Otolaryngol Head Neck Surg. 2001;12(3):144-147. (Pubitemid 33077372)
194. Ahn JH, Han MW, Kim JH, Chung JW, Yoon TH. Therapeutic effectiveness over time of intratympanic dexamethasone as salvage treatment of sudden deafness. Acta Otolaryngol. 2008;128(2):128-131.
195. Ho HG, Lin HC, Shu MT, Yang CC, Tsai HT. Effectiveness of intratympanic dexamethasone injection in sudden-deafness patients as salvage treatment. Laryngoscope. 2004;114(7):1184-1189.
196. Xenellis J, Papadimitriou N, Nikolopoulos T, et al. Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss: a control study. Otolaryngol Head Neck Surg. 2006;134(6):940-945. (Pubitemid 43766563)
197. Plontke SK, Lowenheim H, Mertens J, et al. Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy. Laryngoscope. 2009;119(2):359-369.
198. Van Wijck F, Staecker H, Lefebvre PP. Topical steroid therapy using the Silverstein Microwick in sudden sensorineural hearing loss after failure of conventional treatment. Acta Otolaryngol. 2007;127(10):1012-1017. (Pubitemid 47463755)
199. Plontke S, Lowenheim H, Preyer S, et al. Outcomes research analysis of continuous intratympanic glucocorticoid delivery in patients with acute severe to profound hearing loss: basis for planning randomized controlled trials. Acta Otolaryngol. 2005;125(8):830-839. (Pubitemid 41224102)
200. Lee HS, Kim JM, Kim YJ, Chung DH, Seo BS, Kim SH. Results of intratympanic dexamethasone injection as salvage treatment in idiopathic sudden hearing loss. J Otolaryngol Head Neck Surg. 2008;37(2):263-268.
201. Kilic R, Safak MA, Oguz H, et al. Intratympanic methylprednisolone for sudden sensorineural hearing loss. Otol Neurotol. 2007;28(3):312-316. (Pubitemid 46607900)
202. Dallan I, De Vito A, Fattori B, et al. Intratympanic methylprednisolone in refractory sudden hearing loss: a 27-patient case series with univariate and multivariate analysis. Otol Neurotol. 2010;31(1):25-30.
203. Yeo SW, Lee DH, Jun BC, Park SY, Park YS. Hearing outcome of sudden sensorineural hearing loss: long-term follow-up. Otolaryngol Head Neck Surg. 2007;136(2):221-224.
204. Montano J, Diercks G, Selesnick S. Sudden sensorineural hearing loss. The ASHA Leader. November 4, 2008.
205. Newman CW, Weinstein BE, Jacobson GP, Hug GA. The Hearing Handicap Inventory for Adults: psychometric adequacy and audiometric correlates. Ear Hear. 1990;11(6):430-433.
206. Newman CW, Jacobson GP, Spitzer JB. Development of the Tinnitus Handicap Inventory. Arch Otolaryngol Head Neck Surg. 1996;122(2):143-148. (Pubitemid 26056771)
207. Ventry IM, Weinstein BE. The Hearing Handicap Inventory for the Elderly: a new tool. Ear Hear. 1982;3(3):128-134. (Pubitemid 12008115)
208. Chisolm TH, Johnson CE, Danhauer JL, et al. A systematic review of health-related quality of life and hearing aids: final report of the American Academy of Audiology Task Force on the Health-Related Quality of Life Benefits of Amplification in Adults. J Am Acad Audiol. 2007;18(2):151-183. (Pubitemid 46505480)
209. Valente M, Abrams H, Benson B, et al. Guidelines for the audiologic management of adult hearing impairment. 2008. http:// www.audiology.org/ resources/documentlibrary/Documents/ haguidelines.pdf
210. Hawkins DB. Effectiveness of counseling-based adult group aural rehabilitation programs: a systematic review of the evidence. J Am Acad Audiol. 2005;16(7):485-493. (Pubitemid 43375794)
211. Uppal HS, Ayshford CA, Wilson F. Sudden onset bilateral sensorineural hearing loss: a manifestation of occult breast carcinoma. J Laryngol Otol. 2001;115(11):907-910. (Pubitemid 33702254)
212. Peltomaa M, Pyykko I, Sappala I, Viitanen L, Viljanen M. Lyme borreliosis, an etiological factor in sensorineural hearing loss? Eur Arch Otorhinolaryngol. 2000;257(6):317-322. (Pubitemid 30612323)
213. Jeans AR, Wilkins EG, Bonington A. Sensorineural hearing loss due to secondary syphilis. Int J STD AIDS. 2008;19(5):355-356. (Pubitemid 351748283)
214. Jaffe BF. Clinical studies in sudden deafness. Adv Otorhinolaryngol. 1973;20:221-228.
215. Federspil P. Drug-induced sudden hearing loss and vestibular disturbances. Adv Otorhinolaryngol. 1981;27:144-158.
216. Wackym PA. Molecular temporal bone pathology: II. Ramsay Hunt syndrome (herpes zoster oticus). Laryngoscope. 1997;107(9):1165-1175. (Pubitemid 27382508)
217. Timon CI, Walsh MA. Sudden sensorineural hearing loss as a presentation of HIV infection. J Laryngol Otol. 1989;103(11):1071-1072. (Pubitemid 19278725)
218. Chandrasekhar SS, Siverls V, Sekhar HK. Histopathologic and ultrastructural changes in the temporal bones of HIV-infected human adults. Am J Otol. 1992;13(3):207-214.
219. Mahmoudian T, Modaresi M, Zarei A, Poursafa P, Kelishadi R. Blood lead levels in children with neurological disorders: a single centre preliminary study. Zhongguo Dang Dai Er Ke Za Zhi. 2009;11(11):873-876.
220. Bitner-Glindzicz M. Hereditary deafness and phenotyping in humans. Br Med Bull. 2002;63:73-94. (Pubitemid 35175752)
221. Janecke AR, Hirst-Stadlmann A, Gunther B, et al. Progressive hearing loss, and recurrent sudden sensorineural hearing loss associated with GJB2 mutations-phenotypic spectrum and frequencies of GJB2 mutations in Austria. Hum Genet. 2002;111(2):145-153. (Pubitemid 36075032)
222. Chinnery PF, Elliott C, Green GR, et al. The spectrum of hearing loss due to mitochondrial DNA defects. Brain. 2000;123(pt 1):82-92. (Pubitemid 30037971)
223. Takahashi K, Merchant SN, Miyazawa T, et al. Temporal bone histopathological and quantitative analysis of mitochondrial DNA in MELAS. Laryngoscope. 2003;113(8):1362-1368. (Pubitemid 36944680)
224. Seidman MD, Bai U, Khan MJ, et al. Association of mitochondrial DNA deletions and cochlear pathology: a molecular biologic tool. Laryngoscope. 1996;106(6):777-783. (Pubitemid 26184057)
225. Son EJ, Bang JH, Kang JG. Anterior inferior cerebellar artery infarction presenting with sudden hearing loss and vertigo. Laryngoscope. 2007;117(3):556-558. (Pubitemid 46407772)
226. Huang MH, Huang CC, Ryu SJ, Chu NS. Sudden bilateral hearing impairment in vertebrobasilar occlusive disease. Stroke. 1993;24(1):132-137.
227. Kim JS, Lopez I, DiPatre PL, Liu F, Ishiyama A, Baloh RW. Internal auditory artery infarction: clinicopathologic correlation. Neurology. 1999;52(1):40-44. (Pubitemid 29044397)
228. Berger JR, Jones R, Wilson D. Intravascular lymphomatosis presenting with sudden hearing loss. J Neurol Sci. 2005;232(1- 2):105-109. (Pubitemid 40585850)
229. Houck JR, Murphy K. Sudden bilateral profound hearing loss resulting from meningeal carcinomatosis. Otolaryngol Head Neck Surg. 1992;106(1):92-97.
230. Berg HM, Cohen NL, Hammerschlag PE, Waltzman SB. Acoustic neuroma presenting as sudden hearing loss with recovery. Otolaryngol Head Neck Surg. 1986;94(1):15-22. (Pubitemid 16129881)
231. Kazuchika O, Yoshihiro N, Hisashi T, Akio H, Ken K. Bilateral sensorineural hearing loss in a patient with sarcoidosis. Audiol Japan. 2006;49(3):284-290.
232. Smith JH, Stovall KC, Coons S, Fife TD. Bilateral vestibular hypofunction in neurosarcoidosis: a case report. Ear Nose Throat J. 2011;90(1):E1-E3.
233. Finger RP, Gostian AO. Apheresis for idiopathic sudden hearing loss: reviewing the evidence. J Clin Apher. 2006;21(4):241-245. (Pubitemid 46034438)
234. Ito S, Fuse T, Yokota M, et al. Prognosis is predicted by early hearing improvement in patients with idiopathic sudden sensorineural hearing loss. Clin Otolaryngol Allied Sci. 2002;27(6):501-504. (Pubitemid 36042874)
235. Aggarwal S, Pawar M, Banerjee N. Role of hyperbaric oxygen therapy in sudden sensory neural hearing loss (SSNHL). J Anaesthesiol Clin Pharmacol. 2010;26(2):240-242.
236. Muzzi E, Zennaro B, Visentin R, Soldano F, Sacilotto C. Hyperbaric oxygen therapy as salvage treatment for sudden sensorineural hearing loss: review of rationale and preliminary report. J Laryngol Otol. 2010;124(2):e2.
237. Aslan I, Oysu C, Veyseller B, Baserer N. Does the addition of hyperbaric oxygen therapy to the conventional treatment modalities influence the outcome of sudden deafness? Otolaryngol Head Neck Surg. 2002;126(2):121-126. (Pubitemid 41123603)
238. Murakawa T, Kosaka M, Mori Y, Fukazawa M, Misaki K. Treatment of 522 patients with sudden deafness performed oxygenation at high pressure [in Japanese]. Nippon Jibiinkoka Gakkai Kaiho. 2000;103(5):506-515.
239. Desloovere C, Knecht R, Germonpre P. Hyperbaric oxygen therapy after failure of conventional therapy for sudden deafness. B-ENT. 2006;2(2):69-73. (Pubitemid 47528230)
240. Narozny W, Sicko Z, Przewozny T, Stankiewicz C, Kot J, Kuczkowski J. Usefulness of high doses of glucocorticoids and hyperbaric oxygen therapy in sudden sensorineural hearing loss treatment. Otol Neurotol. 2004;25(6):916-923. (Pubitemid 39491672)
241. Lamm K, Lamm H, Arnold W. Effect of hyperbaric oxygen therapy in comparison to conventional or placebo therapy or no treatment in idiopathic sudden hearing loss, acoustic trauma, noise-induced hearing loss and tinnitus: a literature survey. Adv Otorhinolaryngol. 1998;54:86-99.
242. Ohno K, Noguchi Y, Kawashima Y, Yagishita K, Kitamura K. Secondary hyperbaric oxygen therapy for idiopathic sudden sensorineural hearing loss in the subacute and chronic phases. J Med Dent Sci. 2010;57(2):127-132.
243. Suzuki H, Fujimura T, Shiomori T, et al. Prostaglandin E1 versus steroid in combination with hyperbaric oxygen therapy for idiopathic sudden sensorineural hearing loss. Auris Nasus Larynx. 2008;35(2):192-197. (Pubitemid 351474579)
244. Fujimura T, Suzuki H, Shiomori T, Udaka T, Mori T. Hyperbaric oxygen and steroid therapy for idiopathic sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol. 2007;264(8):861-866. (Pubitemid 47025050)
245. Choung YH, Park K, Shin YR, Cho MJ. Intratympanic dexamethasone injection for refractory sudden sensorineural hearing loss. Laryngoscope. 2006;116(5):747-752. (Pubitemid 44318031)
246. Dallan I, Bruschini L, Nacci A, et al. Transtympanic steroids as a salvage therapy in sudden hearing loss: preliminary results. ORL J Otorhinolaryngol Relat Spec. 2006;68(5):247-252. (Pubitemid 44352662)
247. Roebuck J, Chang CY. Efficacy of steroid injection on idiopathic sudden sensorineural hearing loss. Otolaryngol Head Neck Surg. 2006;135(2):276-279. (Pubitemid 44142144)
248. Plaza G, Herraiz C. Intratympanic steroids for treatment of sudden hearing loss after failure of intravenous therapy. Otolaryngol Head Neck Surg. 2007;137(1):74-78. (Pubitemid 46962140)
249. Gouveris H, Selivanova O, Mann W. Intratympanic dexamethasone with hyaluronic acid in the treatment of idiopathic sudden sensorineural hearing loss after failure of intravenous steroid and vasoactive therapy. Eur Arch Otorhinolaryngol. 2005;262(2):131-134. (Pubitemid 40386323)
250. Silverstein H, Choo D, Rosenberg SI, Kuhn J, Seidman M, Stein I. Intratympanic steroid treatment of inner ear disease and tinnitus (preliminary report). Ear Nose Throat J. 1996;75(8):468- 471, 474, 476 passim.
251. Kopke RD, Hoffer ME, Wester D, O'Leary MJ, Jackson RL. Targeted topical steroid therapy in sudden sensorineural hearing loss. Otol Neurotol. 2001;22(4):475-479. (Pubitemid 32661944)